Exercise for Chronic Pediatric Conditions
(Project REACH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how exercise affects children with chronic conditions such as cystic fibrosis (CF), sickle cell disease (SCD), and those who have had COVID-19. Exercise tests measure how these children's bodies respond to physical activity. The goal is to develop better methods to test and improve exercise plans for them. Children with CF or SCD, or those who have experienced COVID-19 and can exercise without issues, might be suitable candidates for this study. As an unphased trial, this study offers a unique opportunity for children to contribute to research that could enhance exercise plans for others with similar conditions.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions that chronic medication use is an exclusion criterion for healthy controls and those with a history of SARS-CoV-2 infection. It's best to discuss your specific medications with the trial coordinators.
What prior data suggests that this exercise protocol is safe for children with chronic conditions?
Research shows that exercise is generally safe for children with conditions like cystic fibrosis (CF), a history of COVID-19, and sickle cell disease (SCD). For children with CF, studies indicate that exercise rarely causes side effects, making it a safe way to boost fitness and health.
In children who have had COVID-19, most do not experience heart or lung problems from mild infections, suggesting that exercise is safe for them too.
For those with sickle cell disease, recent research suggests that controlled exercise does not cause problems and is well tolerated, indicating it is generally safe and can be helpful.
Overall, exercise appears to be a safe and beneficial activity for kids with these chronic conditions, improving their health and quality of life.12345Why are researchers excited about this trial?
Researchers are excited about the exercise protocol being tested because it offers a non-invasive way to boost health in children with chronic conditions like cystic fibrosis, past SARS-CoV-2 infection, and sickle cell disease. Unlike conventional treatments that often rely on medication, this approach focuses on improving cardiorespiratory fitness through structured exercise, potentially offering fewer side effects. Additionally, the study aims to gather important data on how exercise impacts blood markers, providing insights that could lead to personalized exercise recommendations for these conditions.
What evidence suggests that this trial's exercise treatments could be effective for chronic pediatric conditions?
This trial will evaluate the effects of exercise on children with chronic conditions, including cystic fibrosis (CF), sickle cell disease (SCD), and those with a history of COVID-19 infection. Research has shown that exercise can be very helpful for these groups. Participants in the CF arm may experience improved lung function, fitness, and overall quality of life through regular exercise, which also strengthens muscles and heart health. In the arm for children with a history of COVID-19, exercise can improve heart and lung fitness and general health, addressing the reduced activity levels seen during the pandemic. For those in the SCD arm, light to moderate exercise is generally safe and can aid in muscle growth. Although some debate exists, exercise is usually seen as a beneficial addition to treatment plans for these conditions.16789
Are You a Good Fit for This Trial?
Children aged approximately 10-17 with cystic fibrosis, sickle cell disease, or past SARS-CoV-2 infection are eligible for this exercise study if they're in good health and have no other conditions that limit physical activity. They must be at a stage of puberty as defined by Tanner stages 1-5 and have physician approval to perform exercise tests.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Cardiopulmonary Exercise Test (CPET) to measure cardiorespiratory responses, with blood sampling at multiple time points
Follow-up
Participants are monitored for safety and effectiveness after treatment, including gene expression and body composition assessments
What Are the Treatments Tested in This Trial?
Interventions
- Exercise
Trial Overview
The REACH project is testing how children with chronic diseases respond to exercise. It aims to develop new ways of measuring the effects of physical activity on kids with genetic diseases like cystic fibrosis and sickle cell disease, as well as those affected by COVID-19.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Active Control
Cardiopulmonary Exercise Test (CPET) will be performed to measure cardiorespiratory responses in children with Children With Sickle Cell Disease (SCD). Exercise will consist of up to 8, 2 minutes bouts of constant work rate cycle ergometry with 1 minute resting intervals between each exercise bout. A subgroup of children will be asked to allow the investigators to obtain blood samples during the exercise session. The following procedures will occur: * The child will be in a fasted state. * An IV will be placed into the child's arm. * Blood sampling will be taken at 4 time points; baseline, and the end of exercise, and at 30 and 60 minutes post exercise.
Cardiopulmonary Exercise Test (CPET) will be performed to measure cardiorespiratory responses in children with a documented history of SARS CoV-2 Infection. Exercise will consist of up to 8, 2 minutes bouts of constant work rate cycle ergometry with 1 minute resting intervals between each exercise bout. A subgroup of children will be asked to allow the investigators to obtain blood samples during the exercise session. The following procedures will occur: * The child will be in a fasted state. * An IV will be placed into the child's arm. * Blood sampling will be taken at 4 time points; baseline, and the end of exercise, and at 30 and 60 minutes post exercise.
Cardiopulmonary Exercise Test (CPET) will be performed to measure cardiorespiratory responses in children with Children With Cystic Fibrosis (CF). Exercise will consist of up to 8, 2 minutes bouts of constant work rate cycle ergometry with 1 minute resting intervals between each exercise bout. A subgroup of children will be asked to allow the investigators to obtain blood samples during the exercise session. The following procedures will occur: * The child will be in a fasted state. * An IV will be placed into the child's arm. * Blood sampling will be taken at 4 time points; baseline, and the end of exercise, and at 30 and 60 minutes post exercise.
Cardiopulmonary Exercise Test (CPET) will be performed to measure cardiorespiratory responses in healthy controls. Exercise will consist of up to 8, 2 minutes bouts of constant work rate cycle ergometry with 1 minute resting intervals between each exercise bout. A subgroup of children will be asked to allow the investigators to obtain blood samples during the exercise session. The following procedures will occur: * The child will be in a fasted state. * An IV will be placed into the child's arm. * Blood sampling will be taken at 4 time points; baseline, and the end of exercise, and at 30 and 60 minutes post exercise.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Irvine
Lead Sponsor
Children's Hospital of Orange County
Collaborator
Children's Hospital Los Angeles
Collaborator
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
Children's Hospital of Orange County (CHOC)
Collaborator
Children's Hospital of Los Angeles (CHLA)
Collaborator
Lurie Children's Hospital in Chicago
Collaborator
Published Research Related to This Trial
Citations
Exercise Training in Children and Adolescents with Cystic ...
Regular exercise training is associated with improved aerobic and anaerobic capacity, higher pulmonary function, and enhanced airway mucus clearance.
The Impact of Physical Activity on Clinical Outcomes in ...
Emerging evidence supports the role of physical exercise in improving lung function, aerobic capacity, and quality of life in pediatric CF patients.
The effect of endurance, resistance and concurrent training ...
The purpose of this study was to determine the effects of three exercise-training programs on respiratory capacity and pulmonary function in patients with CF.
Effectiveness of Physical Exercise Interventions on ...
Conclusions: Exercise interventions in children and adults with CF are effective in improving muscle strength, cardiovascular capacity, and respiratory muscle ...
The effectiveness of exercise interventions to increase ...
Physical activity (PA) and exercise have numerous benefits in Cystic Fibrosis (CF) including improved lung function, exercise capacity and ...
Physical activity and exercise training in cystic fibrosis - PMC
Side effects of physical activity are rare, so it can be considered safe in CF (Ruf 2010). Why it is important to do this review. This review aims to provide ...
Exercise and physical activity in children with cystic fibrosis
Higher levels of exercise capacity have been reported to be important for survival in patients with CF. Several studies have demonstrated an association between ...
Physical activity and exercise training in cystic fibrosis
Side effects of physical activity are rare, so it can be considered safe in CF (Ruf 2010). Why it is important to do this review. This review ...
Home-based exercise programs in cystic fibrosis: Are they ...
This 1-year program resulted in major improvements in forced vital capacity, FEV1, and aerobic fitness.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.